Schedule 13D ownership disclosure
VOR BIOPHARMA INC
Common Stock, par value $.0001 per share · CUSIP: 929033108
Event date: 2024-12-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Reprogrammed Interchange LLCReported CIK 0002050755
Shares: 38,974,101.00 · Class: 31.3%
- Reid HoffmanReported CIK 0001519339
Shares: 38,974,101.00 · Class: 31.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-001009
- Form type
- SCHEDULE 13D
- Filer
- Reprogrammed Interchange LLC
- CIK
- CIK 2050755
- Filed
- Jan 07, 2025
- Reporting period
- Dec 30, 2024
- Description
- Schedule 13D beneficial ownership